Keyphrases
Angiotensin-converting Enzyme 2 (ACE2)
20%
Anti-B Cell Therapy
20%
Bendamustine
20%
Chemotherapy
20%
Chronic Lymphocytic Leukemia
20%
COVID-19
100%
Ct Value
20%
Cultured Cells
20%
Hematological Malignancies
40%
High Concentration
20%
Immunocompromised Adults
60%
Immunocompromised Host
20%
Immunocompromised Patients
100%
Initial Diagnosis
20%
Marginal Zone Lymphoma
20%
Nasopharyngeal Swab
20%
Obinutuzumab
20%
Plaque Assay
20%
Positive Check
20%
Pregenomic RNA (pgRNA)
20%
QPCR Assay
20%
Quantitative PCR
100%
Risk Factors
20%
Rituximab
20%
RT-PCR Test
40%
SARS-CoV-2 Antigen
20%
SARS-CoV-2 PCR
20%
SARS-CoV-2 RT-PCR
40%
SARS-CoV-2 Transmission
20%
SARS-CoV-2 Virus
20%
Solid Organ Transplant
20%
Titer
20%
Transmembrane Protease Serine 2 (TMPRSS2)
20%
Venetoclax
20%
Vero
20%
Viral Culture
100%
Viral Methods
20%
Viral Shedding
20%
Viral Titer
40%
Virus
40%
Medicine and Dentistry
B Cell
12%
B-Cell Chronic Lymphocytic Leukemia
12%
Bendamustine
12%
Cell Culture
100%
Chemotherapy
12%
Coronavirinae
12%
COVID-19
12%
Hematologic Malignancy
25%
Immunocompromised Patient
100%
MALT Lymphoma
12%
Nasopharyngeal Swab
12%
Obinutuzumab
12%
Plaque Assay
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Reverse Transcription Polymerase Chain Reaction
100%
Rituximab
12%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Transplantation
12%
Venetoclax
12%
Viral Cell
100%
Virus RNA
12%
Virus Shedding
12%